|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
Water-soluble packaging has enjoyed a resurgence of interest from manufacturers, retailers and marketing professionals alike, as technology has taken capabilities far beyond anything previously imagined. The pharmaceutical industry recognised the importance of these developments and, in recent years, has pushed for even further advancements to be made to meet their individual requirements.
In our busy lifestyles we almost take packaging for granted, hardly noticing that it is there. However, there are hardly any products, which do not come into contact with packaging during manufacture, distribution, storage or use. Pharmaceutical products are certainly no exception to this and packaging plays a particularly important role within this sector.
Packaging has a number of important roles. It has to contain the product, protect and preserve it and provide information about the contents and their usage. Pharmaceutical products in particular are subjected to multiple handling through wholesalers, distributors, pharmacies and retailers and so packaging needs to be carefully selected. In addition, the information contained within and on packaging is possibly more important within this sector than just about any other industry. Pharmaceutical packaging buyers and specifiers have to investigate their requirements in as much detail as any other sector and this thoroughness by the industry has led to many changes in practice and new developments over the last few decades.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals
Heilbronn/Dortmund August 2019: Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like multiple sclerosis, rheumatoid arthritis or cancer they are considered the future of treatment. Also economically biological drugs are on their way up: The global biopharmaceuticals market is anticipated to reach about 400 billion USD by 2025. Which strategic alignment will help best to fill a successful pipeline?
More info >> |
|
 |
White Papers |
 |
|
Clinical Trials in Russia Orange Paper: 1st Quarter 2014
Synergy Research Group
In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia:
1. Fast patient enrollment due to the centralized medical infrastructure.
2. Nearly 100% patient retention
3. GCP trained and certified Investigative Sites generating high quality data
4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >> |
|
 |
Industry Events |
 |
CPhI & P-MEC India
26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India
As
the pharma
industry looks increasingly towards India forhigh quality, low cost pharma solutions, CPhI & P-MEC Indiais the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer.
At
CPhI & P-MEC India, you will meet the movers and shakers from India’s
pharma machinery, technology and ingredients industries, giving you a
competitive advantage that will help grow your business.
More info >> |
|
|
